PepGen Inc. (PEPG)
2.36
-0.05
(-2.07%)
USD |
NASDAQ |
Oct 30, 16:00
2.345
-0.02
(-0.64%)
After-Hours: 20:00
PepGen Cash from Investing (Quarterly) : -3.516M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.516M |
| March 31, 2026 | -1.459M |
| December 31, 2025 | -66.24M |
| September 30, 2025 | 18.90M |
| June 30, 2025 | 14.96M |
| March 31, 2025 | 17.15M |
| December 31, 2024 | 26.50M |
| September 30, 2024 | -0.133M |
| June 30, 2024 | -52.74M |
| March 31, 2024 | -11.29M |
| December 31, 2023 | -29.59M |
| September 30, 2023 | -0.225M |
| Date | Value |
|---|---|
| June 30, 2023 | -1.009M |
| March 31, 2023 | -1.181M |
| December 31, 2022 | -1.102M |
| September 30, 2022 | -0.43M |
| June 30, 2022 | -0.609M |
| March 31, 2022 | -1.614M |
| December 31, 2021 | -0.156M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -0.305M |
| December 31, 2020 | -0.006M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 0.00 |
| IRulya Therapeutics, Inc. | 8.001M |
| Q32 Bio, Inc. | 0.00 |
| Bridgebio Oncology Therapeutics, Inc. | 45.73M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.81M |
| Cash from Financing (Quarterly) | -0.065M |
| Free Cash Flow | -69.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2288 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -48.76% |